• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名晚期人类免疫缺陷病毒病患者的猴痘复发与特考韦瑞耐药性

Mpox Recurrence and Tecovirimat Resistance in a Patient With Advanced Human Immunodeficiency Virus Disease.

作者信息

Griffith David C, Fall Amary, Carter Mihaela, Traut Caroline C, Sop Joel, Hansoti Bhakti, Gebo Kelly A, Mostafa Heba H, Blankson Joel N

机构信息

Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

出版信息

Open Forum Infect Dis. 2024 Sep 23;11(10):ofae549. doi: 10.1093/ofid/ofae549. eCollection 2024 Oct.

DOI:10.1093/ofid/ofae549
PMID:39371365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11452800/
Abstract

We present a case of mpox recurrence in a transgender woman with AIDS. Her recurrent lesions required several courses of antiviral therapy over a 5-month period and her monkeypox viral genome was subsequently noted to have tecovirimat resistance mutations. Interestingly, she developed a robust orthopoxvirus-specific T-cell response.

摘要

我们报告了一例患有艾滋病的跨性别女性猴痘复发的病例。她的复发性皮损在5个月内需要接受多个疗程的抗病毒治疗,随后发现她的猴痘病毒基因组存在对特考韦瑞有抗性的突变。有趣的是,她产生了强烈的正痘病毒特异性T细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/407c/11452800/4bea83f3b3ac/ofae549f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/407c/11452800/d0682f7fd9e7/ofae549f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/407c/11452800/4bea83f3b3ac/ofae549f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/407c/11452800/d0682f7fd9e7/ofae549f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/407c/11452800/4bea83f3b3ac/ofae549f2.jpg

相似文献

1
Mpox Recurrence and Tecovirimat Resistance in a Patient With Advanced Human Immunodeficiency Virus Disease.一名晚期人类免疫缺陷病毒病患者的猴痘复发与特考韦瑞耐药性
Open Forum Infect Dis. 2024 Sep 23;11(10):ofae549. doi: 10.1093/ofid/ofae549. eCollection 2024 Oct.
2
Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.2022 年美国免疫功能低下患者疑似特考韦瑞玛耐药性猴痘的治疗。
Emerg Infect Dis. 2023 Dec;29(12):2520-2523. doi: 10.3201/eid2912.230849. Epub 2023 Oct 19.
3
Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.2022-2023 年美国猴痘患者中特考韦瑞玛的耐药情况。
Emerg Infect Dis. 2023 Dec;29(12):2426-2432. doi: 10.3201/eid2912.231146. Epub 2023 Oct 19.
4
Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin Lesions.艾滋病毒感染者中出现的猴痘疾病持续时间延长:猴痘皮肤损伤特征。
J Infect Dis. 2024 Mar 26;229(Supplement_2):S243-S248. doi: 10.1093/infdis/jiad532.
5
Repurposing of the antibiotic nitroxoline for the treatment of mpox.将抗生素硝咯喹啉重新用于治疗猴痘。
J Med Virol. 2023 Mar;95(3):e28652. doi: 10.1002/jmv.28652.
6
Tecovirimat for the treatment of severe Mpox in Germany.特考韦瑞用于德国严重猴痘的治疗。
Infection. 2023 Oct;51(5):1563-1568. doi: 10.1007/s15010-023-02049-0. Epub 2023 Jun 5.
7
Surveillance of Complicated Mpox Cases Unresponsive to Oral Tecovirimat in Los Angeles County, 2022.洛杉矶县 2022 年口服特考韦瑞玛特治疗无效的复杂猴痘病例监测。
J Infect Dis. 2024 Mar 26;229(Supplement_2):S249-S254. doi: 10.1093/infdis/jiad517.
8
Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.天花病毒 Tecovirimat 静脉注射制剂的监管审批概述:对天花爆发应对能力的潜在影响,以及 Tecovirimat 的未来开发潜力。
Expert Rev Anti Infect Ther. 2023 Mar;21(3):235-242. doi: 10.1080/14787210.2023.2170350. Epub 2023 Feb 2.
9
Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients.在晚期人类免疫缺陷病毒感染中,使用延长疗程抗病毒药物与抗逆转录病毒药物联合治疗重症猴痘:4例患者的病例系列
Open Forum Infect Dis. 2024 Feb 27;11(3):ofae110. doi: 10.1093/ofid/ofae110. eCollection 2024 Mar.
10
Mpox in people with advanced HIV infection: a global case series.晚期HIV感染者中的猴痘:一项全球病例系列研究。
Lancet. 2023 Mar 18;401(10380):939-949. doi: 10.1016/S0140-6736(23)00273-8. Epub 2023 Feb 21.

引用本文的文献

1
Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals.规避传统抗病毒药物出现耐药性的策略与努力。
NPJ Antimicrob Resist. 2025 Jun 9;3(1):54. doi: 10.1038/s44259-025-00125-z.
2
Discovery of -Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus.发现 - 三氟甲基苯甲酰肼衍生物作为抗猴痘病毒的强效抗病毒剂。
ACS Med Chem Lett. 2025 Apr 7;16(5):837-843. doi: 10.1021/acsmedchemlett.5c00075. eCollection 2025 May 8.
3
Atypical mucocutaneous manifestations of MPOX: A systematic review.

本文引用的文献

1
Risk Factors for Hospitalization and Effect of Immunosuppression on Clinical Outcomes Among an Urban Cohort of Patients With Mpox.城市地区猴痘患者队列中住院的危险因素及免疫抑制对临床结局的影响
Open Forum Infect Dis. 2023 Dec 5;10(12):ofad533. doi: 10.1093/ofid/ofad533. eCollection 2023 Dec.
2
Description of mpox reinfection by whole genome sequencing.通过全基因组测序描述猴痘再感染。
Int J Infect Dis. 2023 Dec;137:111-113. doi: 10.1016/j.ijid.2023.10.017. Epub 2023 Oct 24.
3
Tecovirimat Resistance in Mpox Patients, United States, 2022-2023.
猴痘的非典型皮肤黏膜表现:一项系统评价
J Dermatol. 2025 Feb;52(2):228-238. doi: 10.1111/1346-8138.17605. Epub 2025 Jan 3.
2022-2023 年美国猴痘患者中特考韦瑞玛的耐药情况。
Emerg Infect Dis. 2023 Dec;29(12):2426-2432. doi: 10.3201/eid2912.231146. Epub 2023 Oct 19.
4
Mpox in people with past infection or a complete vaccination course: a global case series.既往感染或全程接种疫苗人群中的猴痘:全球病例系列研究。
Lancet Infect Dis. 2024 Jan;24(1):57-64. doi: 10.1016/S1473-3099(23)00492-9. Epub 2023 Sep 4.
5
Case Report: Recurrent Mpox in a Healthcare Worker in Nigeria.病例报告:尼日利亚一名医护人员反复感染猴痘。
Am J Trop Med Hyg. 2023 Aug 21;109(4):858-860. doi: 10.4269/ajtmh.23-0232. Print 2023 Oct 4.
6
Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.猴痘恢复期患者的痘病毒特异性 T 细胞应答。
J Infect Dis. 2024 Jan 12;229(1):54-58. doi: 10.1093/infdis/jiad245.
7
Identification of Tecovirimat Resistance-Associated Mutations in Human Monkeypox Virus - Los Angeles County.在洛杉矶县人类猴痘病毒中鉴定替考韦瑞玛耐药相关突变
Antimicrob Agents Chemother. 2023 Jul 18;67(7):e0056823. doi: 10.1128/aac.00568-23. Epub 2023 Jun 20.
8
Development of an amplicon-based sequencing approach in response to the global emergence of mpox.针对猴痘在全球的出现,开发了一种基于扩增子的测序方法。
PLoS Biol. 2023 Jun 13;21(6):e3002151. doi: 10.1371/journal.pbio.3002151. eCollection 2023 Jun.
9
Mpox in a Couple Living with HIV: Relapse or Reinfection?一对感染艾滋病毒夫妇中的猴痘:复发还是再感染?
AIDS Res Hum Retroviruses. 2023 Nov;39(11):610-615. doi: 10.1089/AID.2022.0189. Epub 2023 Jun 7.
10
Suspected case of monkeypox reinfection versus reactivation in a immunocompetent patient, Barcelona, 2022.2022 年,巴塞罗那一名免疫功能正常的患者疑似猴痘再感染与再激活病例。
Int J STD AIDS. 2023 Aug;34(9):649-652. doi: 10.1177/09564624231162426. Epub 2023 Apr 26.